Practice question

Marker-assisted selection replaces unreliable phenotypic screening with direct interrogation of DNA sequence polymorphisms linked to trait-controlling loci. Instead of measuring disease severity in field that depends on weather and inoculum load, MAS uses polymerase chain reaction amplification of SSR, SNP, or SCAR markers situated within few centimorgans of target gene, detecting presence of donor allele regardless of environment, plant stage, or dominance interactions. Segregating individuals are genotyped at seedling stage, selection made before flowering, accelerating backcross programs and enabling pyramiding of multiple resistance genes that are phenotypically indistinguishable. DNA markers are codominant, neutral, abundant across genome, and not influenced by G×E interaction, so breeding value predicted from marker haplotype reflects genotype faithfully. This paradigm shift from phenotype to genotype selection improves efficiency for traits difficult to score such as root characters, quality, and recessive alleles and reduces phenotyping costs. Functional markers derived from causal genes such as Pi21, Wx1, and opaque2 provide perfect selection accuracy; KASP and TaqMan SNP assays enable high throughput automated genotyping in breeding pipeline, allowing selection at seedling stage and rapid cycling without field phenotyping or biochemical assays for quality traits.